SILVER SPRING, Md., Feb. 27, 2020 /PRNewswire/ -- As I have previously communicated, the FDA has been closely monitoring the supply chain with the expectation that the COVID-19 outbreak would likely impact the medical product supply chain, including potential disruptions to supply or...
from PR Newswire: https://ift.tt/2PzliFs
No comments:
Post a Comment